Kalorama InformationKalorama Information, a division of MarketResearch.com, is a leader in worldwide business intelligence and syndicated market research in the life sciences. With a more than 30-year history of providing timely, high-quality research to decision makers in the pharmaceutical, biotechnology, medical device, and diagnostics sectors, Kalorama comprehensively researches the market sectors and healthcare trends that matter most to emerging and established life science firms.
|
View Sample from this Publisher Adobe Acrobat required |
Our Products & Services
Kalorama Information Market Profiles are in-depth analyses of specific markets based on extensive interviews with industry experts, unique market modeling techniques, and comprehensive secondary research. Generally several hundred pages in length, Market Profiles provide market size; growth rates; market share and profiles of market leaders, including technologies, products, and business strategies; and analysis of major clinical, demographic, and regulatory trends.
Kalorama Information MarketLooks are detail- and graphic-rich reports consisting of the top-level findings, charts, and graphs from our longer, full-length Market Profiles. Typically 15-30 pages in length, MarketLooks provide primary research findings from full reports to accommodate those with limited research budgets or limited time to ramp up on a topic. The electronic format of these reports makes them easy to integrate into internal presentations and reports.
Kalorama DeviceLooks are concise profiles of specific medical device markets providing key market information with a strong emphasis on data and graphics. Ranging from 30-50 pages in length, DeviceLooks provide the data that matters for the medical device industry in an affordable format.
Our Team
Steven Heffner, Acquisitions Editor
Steven Heffner has been involved in publishing information for healthcare professionals for 15 years. He began in peer-reviewed clinical literature, editing the Current Opinion line of clinical medical journals. Later, his focus shifted to healthcare books, and held editorships at Faulkner & Gray’s Healthcare Information Center, specializing in books on managed care policy, and most recently at Theta Reports, part of PJB Medical Publishing. Steven joined Kalorama in the spring of 2001. He personally commissions and edits all of Kalorama research studies to ensure that they are consistently of the highest quality. Steven can be reached at sheffner@kaloramainformation.com.
Our Industry Specialists
Kalorama Information’s Industry Specialists are dedicated to serving you and meeting your information needs. Whether you need help browsing through our collection or require advice about which particular research will best suit your needs, our Industry Specialists are here to help. Contact an Industry Specialist today at 1-800-298-5602 or (212) 807-2660 outside the U.S.
Why Buy from Us?
Our Independent Voice
With Kalorama studies you get:
Our Quality Analysts
Kalorama’s analysts are experienced researchers in their fields who provide you with:
Our Research Methodology
Kalorama Information studies include data gathered the old-fashioned way – through primary research. Our market studies are based on independent primary research conducted by analysts with years of experience in the industry. They build their market analysis from the ground up, validating data with inside industry contacts and extensive secondary research, not by regurgitating numbers from an enormous database you already have. Extensive interviewing of industry executives, clinical practitioners, government policy makers, and respected consultants form the basis of every Kalorama study. Secondary sources, such as regulatory filings, company literature, press reports, and commercial databases, are relied upon to validate market assumptions and detail industry events.
List of reports from Kalorama Information
|
White Paper: Bariatric Surgery Trends
12/19/2011 | published by: Kalorama Information
... United States for Women and for Men, and describes the surgeries. The White Paper is based on information from Kalorama Information's complete review of the gastrointestinal device market, KLI6710760 The World Market for Gastrointestinal Devices
|
more...
|
|
|
Mabs vs. TKIs: Two Paths to Cancer Targeting -White Paper
11/1/2011 | published by: Kalorama Information
... system target cancer cells. From a market perspective there has been an interesting trend as revenues for TKI products such as Gleevec have continued to grow. This White Paper from Kalorama Information describes this trend. ...
|
more...
|
|
|
3 Key Trends in MRI White Paper
3/6/2012 | published by: Kalorama Information
... applications for this growing imaging modality. This Kalorama White Paper discusses general trends does not replace the thorough analysis in our full survey of the market for MRI - Medical Imaging Markets: MRI and Ultrasound.
|
more...
|
|
|
White Paper - HAI Treatments: A Challenging Market
8/25/2011 | published by: Kalorama Information
... billion earned in 2010 by companies selling pharmaceutical treatments. But it is a market that has seen declines for a variety of reasons, and even as the greatest threats emerge, it may take a few ...
|
more...
|
|
|
White Paper - The Reality of IVD in the BRIC Nations
6/30/2011 | published by: Kalorama Information
... new growth outside of developed countries, in some cases also means new challenges. The growing economies of the 'BRIC Nations' - Brazil, Russia, India and China - will see increased demand for healthcare services led ...
|
more...
|
|
|
White Paper- Biomaterials Boost Med Device Margins
10/17/2011 | published by: Kalorama Information
... provides some information on this trend. Information from this White Paper was obtained from Kalorama's full market study on this market 'The World Market for Orthopedic Biomaterials SKU KLI6329663," as well as news media sources.
|
more...
|
|
|
White Paper: Clinical Trial Outsourcing in BRIC Countries
3/22/2012 | published by: Kalorama Information
... Paper provides a brief look at Outsourcing in Brazil, Russia, China and India. It is based on the information in our report. Outsourcing in Drug Development: The Clinical Trial, CRO Market, available from Kalorama Information.
|
more...
|
|
|
White Paper - Retail Clinics: Winners and Losers 2009-2011
5/1/2011 | published by: Kalorama Information
... providing a time-saving and cost-saving solution for customers of grocery stores, Walmart and drug stores, economics was added to the burden of taking on the existing healthcare system in many respects. The concept has survived, ...
|
more...
|
|
|
White Paper: Why Hospitals are Choosing Handhelds
4/19/2012 | published by: Kalorama Information
... Kalorama's small-sample survey of US hospitals where Kalorama asked for the primary reason hospitals were making handheld purchases a priority. The White Paper is based on information in Kalorama Information's Handhelds in Healthcare report http://www.kaloramainformation.com/Handhelds-Healthcare-Smartphones-6789230/
|
more...
|
|
|
White Paper - POC Testing and the Developing World
10/1/2011 | published by: Kalorama Information
... use of rapid tests for emerging infectious diseases. It is based on material from Kalorama's Point of Care Diagnostics for Emerging Infectious Disease Threats SKUKLI6429399, a complete market research available for purchase on this site.
|
more...
|
|
|
White Paper: Tests That Personalize Show Faster Revenue Growth
4/6/2012 | published by: Kalorama Information
... growth than the IVD industry standard. The White Paper defines Personalized Medicine Diagnostics and provides examples of growth rates of personalized tests. This brief White Paper is based on information in Kalorama Information's full market ...
|
more...
|
|
|
Stark Exemptions and EMR: A Look at Hospital Purchases for Affiliated Physicians
7/1/2011 | published by: Kalorama Information
... comes to EMR purchases. In this brief White Paper, Kalorama Information looks at the concept and its impact on the EMR market. The paper also looks at the status of hospital usage of EMR systems.
|
more...
|
$1.00
|
|
Patient Monitoring Systems: The Fastest-Growing Medical Device?
10/1/2011 | published by: Kalorama Information
... drivers behind the growth of patient monitoring systems. Hospitals and payors are increasing demand for systems. The White Paper also looks at examples of wirless PM systems in action and discusses competitors in the field. ...
|
more...
|
$50.00
|
|
Effective Competitive Intelligence: A "How-To" Guide for Life Science Companies
11/1/2008 | published by: Kalorama Information
... harmful to their business. But how does one know if they are conducting their company's CI in the best way? If you are trying to determine how to use competitive intelligence better, if you are ...
|
more...
|
$195.00
|
|
U.S. Markets in Analytical Chip Technology: Gene, Protein, Tissue, Cell, and Microbiological Microarrays
3/1/2003 | published by: Kalorama Information
... pharmaceutical development, food testing, clinical diagnostics, forensics, and environmental analysis. Moreover, while the number of such products is currently limited, the number of applications is rapidly expanding through the development of significant enabling technologies. Where ...
|
more...
|
$250.00
|
|
Healthcare Reform: Winners and Losers
5/1/2010 | published by: Kalorama Information
... players in the healthcare industry, including: Uninsured Consumers Insured Consumers Physicians, Primary Care Physicians, Specialists Retail Clinics Insurance Companies Pharmaceutical Companies Diagnostic Companies Medical Device Companies Biotech Companies Nurse Practitioners Durable Goods Manufacturers The legislation ...
|
more...
|
$250.00
|
|
H1N1 (Swine Influenza) Market Assessment (Latest Data, Company Profiles, Implications for Immunoassays and Molecular Assays)
5/1/2009 | published by: Kalorama Information
... appear in a new report released from Kalorama Information: Swine Flu Market Alert by Kalorama's lead analyst, Shara Rosen. Regardless of the eventual severity of the epidemic, there will be distinct market impact on both ...
|
more...
|
$250.00
|
|
Women's Health: The Market for Menopause, Fertility and Contraceptive Drugs
3/1/2000 | published by: Kalorama Information
... report's detailed market analysis includes historical, current and forecast revenues for each of the product markets. This report projects annual revenue through 2004, examines growth factors, provides in-depth analysis of new products in the research ...
|
more...
|
$350.00
|
|
Advances in Cancer Therapy
2/1/2001 | published by: Kalorama Information
... many cancer patients are managed as if they were chronically ill. These thoughts are being shaped and driven by a variety of forces: A new paradigm that would make use of the patient's natural immune ...
|
more...
|
$350.00
|
|
The Wound Care Market
6/1/1999 | published by: Kalorama Information
... biological skins and dressings. The study examines economic data and the regulatory environment of this market and details the market drivers, challenges and restraints. Competitive analysis, market shares and complete company profiles are provided for ...
|
more...
|
$350.00
|
|
The Market for Home Care Services
11/1/1999 | published by: Kalorama Information
... trends in the market for home care services. Moreover, it profiles leading home care corporations, their lines of business, financial information, home services and corporate strategies. Learn which corporations and services are gaining market share.
|
more...
|
$350.00
|
|
The Market for Rx-to-OTC Switches
6/1/2000 | published by: Kalorama Information
... cost, preference and convenience weighing the market. Segments covered in the report include information on: cold, allergy, sinus and asthma products; analgesics and NSAIDs; antifungals and anti-infectives; gastrointestinal products; and other products. Comprehensive marketing information ...
|
more...
|
$350.00
|
|
Diabetes in Japan: The Markets for Monitoring, Insulin, Oral Hypoglycemics, and Drugs to Treat Complications
4/1/2003 | published by: Kalorama Information
... for drugs primarily marketed to other populations. Segmentation of patient populations in novel ways, such as diabetic candidates for cardiovascular drugs, presents an excellent opportunity to expand markets and influence prescription practices in some markets. ...
|
more...
|
$371.00
|
|
Diabetes in France: The Markets for Monitoring, Insulin, Oral Hypoglycemics, and Drugs to Treat Complications
3/1/2003 | published by: Kalorama Information
... of healthcare policy makers and clinicians—can seem like shifting sands from one country to the next. That’s why Kalorama is now offering affordable country-specific profiles on the diabetes markets that provide you with the facts ...
|
more...
|
$371.00
|
|
Diabetes in Germany: The Markets for Monitoring, Insulin, Oral Hypoglycemics, and Drugs to Treat Complications
4/1/2003 | published by: Kalorama Information
... for drugs primarily marketed to other populations. Segmentation of patient populations in novel ways, such as diabetic candidates for cardiovascular drugs, presents an excellent opportunity to expand markets and influence prescription practices in some markets. ...
|
more...
|
$371.00
|

